Arkema reported +5% (v: +6%; price: +1%; FX: -1%; portfolio: -1%) higher sales (to €1,852m) and the gross profit margin clearly improved from 18.0% to 19.3% in Q4. EBITDA strongly rose +26% to €246m and net profit attributable to shareholders jumped +76% to €86m. Operating CF came down from €380m to €246m, despite the higher operating performance, but NWC inflow declined from €205m to €97m and D/A was also lower. Investing CF moved from €-19m to €-
28 Feb 2017
Not the typical seasonality – more resilience ahead?
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Not the typical seasonality – more resilience ahead?
Arkema SA (AKE:WBO) | 0 0 0.4% | Mkt Cap: 7,655m
- Published:
28 Feb 2017 -
Author:
Martin Schnee -
Pages:
3
Arkema reported +5% (v: +6%; price: +1%; FX: -1%; portfolio: -1%) higher sales (to €1,852m) and the gross profit margin clearly improved from 18.0% to 19.3% in Q4. EBITDA strongly rose +26% to €246m and net profit attributable to shareholders jumped +76% to €86m. Operating CF came down from €380m to €246m, despite the higher operating performance, but NWC inflow declined from €205m to €97m and D/A was also lower. Investing CF moved from €-19m to €-